AKT1 and neoplasm: In fact in bladder, breast, ovarian and lung cancer, it was observed that miR-125b tumor suppressor level was downregulated and this affected IGF, PI3K/Akt/mTOR, and mitogen activated protein kinase (MAPK) signaling pathways [77].